302 related articles for article (PubMed ID: 26812081)
1. Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy.
Caritis S; Zhao Y; Chen HJ; Venkataramanan R
Am J Obstet Gynecol; 2016 Jul; 215(1):93.e1-4. PubMed ID: 26812081
[TBL] [Abstract][Full Text] [Related]
2. Observational Case Series Evaluation of the Granisetron Transdermal Patch System (Sancuso) for the Management of Nausea/Vomiting of Pregnancy.
Le TN; Adler MT; Ouillette H; Berens P; Smith JA
Am J Perinatol; 2017 Jul; 34(9):851-855. PubMed ID: 28231602
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting.
Howell J; Smeets J; Drenth HJ; Gill D
J Oncol Pharm Pract; 2009 Dec; 15(4):223-31. PubMed ID: 19304880
[TBL] [Abstract][Full Text] [Related]
4. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study.
Pope E; Maltepe C; Koren G
J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469
[TBL] [Abstract][Full Text] [Related]
5. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy.
Lacasse A; Rey E; Ferreira E; Morin C; Bérard A
Am J Obstet Gynecol; 2008 Jan; 198(1):71.e1-7. PubMed ID: 18166311
[TBL] [Abstract][Full Text] [Related]
6. Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting.
Schulmeister L
Clin J Oncol Nurs; 2009 Dec; 13(6):711-4. PubMed ID: 19948469
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting.
Bustos ML; Zhao Y; Chen H; Caritis SN; Venkataramanan R
Pharmacotherapy; 2016 Dec; 36(12):1238-1244. PubMed ID: 27809336
[TBL] [Abstract][Full Text] [Related]
8. Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron.
Coluzzi F; Mattia C
Future Oncol; 2016 Aug; 12(16):1865-76. PubMed ID: 27184113
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
10. Measuring outpatient outcomes of emesis and nausea management in pregnant women.
Lombardi DG; Istwan NB; Rhea DJ; O'Brien JM; Barton JR
Manag Care; 2004 Nov; 13(11):48-52. PubMed ID: 15595402
[TBL] [Abstract][Full Text] [Related]
11. Comparison of quince with vitamin B6 for treatment of nausea and vomiting in pregnancy: a randomised clinical trial.
Jafari-Dehkordi E; Hashem-Dabaghian F; Aliasl F; Aliasl J; Taghavi-Shirazi M; Sadeghpour O; Sohrabvand F; Minaei B; Ghods R
J Obstet Gynaecol; 2017 Nov; 37(8):1048-1052. PubMed ID: 28631509
[TBL] [Abstract][Full Text] [Related]
12. Recalling the severity of nausea and vomiting of pregnancy - a study using Pregnancy-Unique Quantification of Emesis Questionnaire.
Laitinen L; Nurmi M; Koivisto M; Rautava P; Polo-Kantola P
J Obstet Gynaecol; 2023 Dec; 43(1):2153025. PubMed ID: 36495300
[TBL] [Abstract][Full Text] [Related]
13. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores.
Koren G; Piwko C; Ahn E; Boskovic R; Maltepe C; Einarson A; Navioz Y; Ungar WJ
J Obstet Gynaecol; 2005 Apr; 25(3):241-4. PubMed ID: 16147725
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
15. Validation of specific questionnaires to assess nausea and vomiting of pregnancy in a French population.
Dochez V; Dimet J; David-Gruselle A; Le Thuaut A; Ducarme G
Int J Gynaecol Obstet; 2016 Sep; 134(3):294-8. PubMed ID: 27262942
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.
Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
BMC Pregnancy Childbirth; 2016 Nov; 16(1):371. PubMed ID: 27881103
[TBL] [Abstract][Full Text] [Related]
17. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone.
Campos D; Pereira JR; Reinhardt RR; Carracedo C; Poli S; Vogel C; Martinez-Cedillo J; Erazo A; Wittreich J; Eriksson LO; Carides AD; Gertz BJ
J Clin Oncol; 2001 Mar; 19(6):1759-67. PubMed ID: 11251007
[TBL] [Abstract][Full Text] [Related]
18. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe nausea and vomiting of pregnancy with subcutaneous medications.
Klauser CK; Fox NS; Istwan N; Rhea D; Rebarber A; Desch C; Palmer B; Saltzman D
Am J Perinatol; 2011 Oct; 28(9):715-21. PubMed ID: 21667429
[TBL] [Abstract][Full Text] [Related]
20. Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale.
Ebrahimi N; Maltepe C; Bournissen FG; Koren G
J Obstet Gynaecol Can; 2009 Sep; 31(9):803-807. PubMed ID: 19941704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
